Re­searchers seek FDA trans­paren­cy on use of sur­ro­gate end­points out­side of on­col­o­gy

In a study pub­lished Mon­day in JA­MA, re­searchers are call­ing on the FDA to share more about how the agency con­sid­ers the use of sur­ro­gate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.